The mayor of a COVID-19 hot spot in Alberta says she’s disappointed that Johnson & Johnson vaccines earmarked for her community are delayed but she values the work Health Canada is doing to ensure every dose is safe. THE CANADIAN PRESS/Virginia Mayo

The mayor of a COVID-19 hot spot in Alberta says she’s disappointed that Johnson & Johnson vaccines earmarked for her community are delayed but she values the work Health Canada is doing to ensure every dose is safe. THE CANADIAN PRESS/Virginia Mayo

Hot spot town expecting J&J COVID-19 vaccine says health officials seeking other sources

Mayor Karen Sorensen issued a statement saying front-line workers are in dire need of the vaccines

The mayor of a COVID-19 hot spot in Alberta says she’s disappointed that Johnson & Johnson vaccines earmarked for her community are delayed, but values the work Health Canada is doing to ensure every dose is safe.

Banff Mayor Karen Sorensen issued a statement saying front-line workers need the vaccines.

She also thanked provincial health officials for exploring other sources to help immunize high-risk areas as soon as possible.

Residents of Banff were among several priority groups across Canada looking forward to the promise of J&J shipments next week.

Plans to distribute the first 300,000 doses are on hold after Health Canada learned part of the vaccines were manufactured at a Maryland facility that messed up the ingredients in 15 million doses bound for the U.S. market.

Health Canada says it’s seeking information from the FDA and J&J’s pharmaceutical arm, Janssen, to determine if the doses shipped to Canada meet required safety standards.

“Like other communities, we will wait our turn and remain vigilant in following all health protocols to stop the spread until everyone is immunized,” Sorensen says.

The Emergent Biosolutions facility in Baltimore was recently cited by the U.S. Food and Drug Administration for violations including cleaning and sterilization failures, the potential for cross-contamination and failure to follow required protocols.

Health Canada had already cleared 1.5 million doses of the Oxford-AstraZeneca vaccine made at the facility but did not think the Canadian J&J doses had any connection to that plant.

Now Health Canada says the drug substance that makes up part of the J&J vaccine was actually produced there and then shipped elsewhere for the vaccines to be completed.

Word of the delay came hours before a number of COVID-19 hot spots reported continued high case counts and troubling virus-related hospitalization rates, though there were signs of hope in some jurisdictions.

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Coronavirusvaccines